| 000 | 01866 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515122834.0 | ||
| 264 | 0 | _c20081209 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1469-896X | ||
| 024 | 7 |
_a10.1110/ps.034199.107 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarnrot, Cecilia | |
| 245 | 0 | 0 |
_aMechanisms of substrate selectivity for Bacillus anthracis thymidylate kinase. _h[electronic resource] |
| 260 |
_bProtein science : a publication of the Protein Society _cSep 2008 |
||
| 300 |
_a1486-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacillus anthracis _xenzymology |
| 650 | 0 | 4 | _aCatalysis |
| 650 | 0 | 4 | _aComputational Biology |
| 650 | 0 | 4 |
_aDeoxyadenine Nucleotides _xmetabolism |
| 650 | 0 | 4 | _aDimerization |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aHistidine _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Weight |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aPyrimidine Nucleosides _xpharmacology |
| 650 | 0 | 4 |
_aRecombinant Proteins _xchemistry |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aThymidine Kinase _xchemistry |
| 650 | 0 | 4 |
_aThymidine Monophosphate _xanalogs & derivatives |
| 700 | 1 | _aWang, Liya | |
| 700 | 1 | _aTopalis, Dimitri | |
| 700 | 1 | _aEriksson, Staffan | |
| 773 | 0 |
_tProtein science : a publication of the Protein Society _gvol. 17 _gno. 9 _gp. 1486-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1110/ps.034199.107 _zAvailable from publisher's website |
| 999 |
_c18015752 _d18015752 |
||